glp 1 for substance use disorder GLP-1 medications get at the heart of addiction: study – WashU Medicine Frontiers | Association between GLP-1

Metformin Reverses Hashimotos Thyroiditis by Regulating Key Immune Events

The results paved the way for liraglutide, branded as Saxenda, to be approved in the US as a once-a-day subcutaneous injection in December 2014 and in Europe in 2015 for the treatment of chronic weight management combined with a reduced calorie diet and increased physical exercise (Molteni, Chen)

Andraos J, Muhar H, Smith S

There is little scientific literature on GLP-1-related hair loss, and its unclear how prevalent the side effect is or whats causing it

Conclusion The arrival of GLP-1 medications offers an exciting new chapter for many people struggling with metabolic health in the UK

Specification: One bottle contains 60 capsules